BIIB - BIOGEN INC.
143.66
-7.050 -4.907%
Share volume: 1,838,069
Last Updated: 03-11-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$150.71
-7.05
-0.05%
Summary score
58%
Profitability
84%
Dept financing
29%
Liquidity
12%
Performance
51%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
3.82%
Return on assets
2.36%
Return on sales
24.63%
Return on invested capital
3.93%
Total debt ratio
47.08%
Debt ratio change over timeo
2.96%
Current Ratio
2.26%
Quick Ratio
1.77%
Cash Position Ratio
0.8%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
3.13%
Return on assets
2.16%
Return on sales
24.36%
Return on invested capital
2.94%
Total debt ratio
41.59%
Debt ratio change over timeo
18.48%
Current Ratio
1.9%
Quick Ratio
1.22%
Cash Position Ratio
0.44%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
2.26%
Return on sales
25.87%
Return on invested capital
0%
Total debt ratio
40.4%
Debt ratio change over time
0%
Current Ratio
1.35%
Quick Ratio
0.9%
Cash Position Ratio
0.43%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-1.18%
Return on assets
-68.37%
Return on sales
249.98%
Return on invested capital
-3.11%
Total debt ratio
296.4%
Debt ratio change over time
2.96%
Current Ratio
25.7%
Quick Ratio
23.55%
Cash Position Ratio
11.75%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BIIB | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 3.82% | 18.63% | 4.21% | 16.49% |
| Return on assets | 2.36% | 3.07% | 3.15% | 15.3% |
| Return on sales | 24.63% | 30.43% | 28.87% | 7.81% |
| Return on invested capital | 3.93% | 5.33% | 2.16% | -56.8% |
| Profitability | 48% | 80% | 45% | 54% |
| Total debt ratio | 47.08% | 92.23% | 67.37% | 20.78% |
| Debt ratio change over time | 2.96% | 18.13% | 116.87% | -1.18% |
| Dept financing | 13% | 29% | 43% | 6% |
| Current Ratio | 1.9% | 1.32% | 1.23% | 11.38% |
| Quick Ratio | 1.22% | 0.95% | 1.08% | 11.16% |
| Cash Position Ratio | 0.44% | 0.47% | 0.47% | 5.59% |
| Liquididy | 20% | 17% | 13% | 75% |
| Short-term ratios | BIIB | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 3.13% | 0% | -23.78% | -1.58% |
| Return on assets | 2.16% | 2.13% | 1.4% | -2.3% |
| Return on sales | 24.36% | 21.39% | 10.21% | -272.71% |
| Return on invested capital | 2.94% | 0% | -14.26% | -13.26% |
| Profitability | 100% | 47% | 27% | 0% |
| Total debt ratio | 41.59% | 93.35% | 67.38% | 10.28% |
| Debt ratio change over time | 18.48% | 0% | 8.62% | -0.69% |
| Dept financing | 36% | 25% | 30% | 3% |
| Current Ratio | 1.9% | 1.32% | 1.23% | 11.38% |
| Quick Ratio | 1.22% | 0.95% | 1.08% | 11.16% |
| Cash Position Ratio | 0.44% | 0.47% | 0.47% | 5.59% |
| Liquididy | 9% | 7% | 7% | 75% |